AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04897334 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Cognitive Therapy
Description: During both the treatment and the sham intervention, participants will undero cognitive therapy training by performing the NBack task. In this sequential letter memory exercise participants are presented with sequential stimuli in the form of a series of letters. For each new stimulus they are asked to indicate if the current stimulus matches the stimulus from 2 trials prior. This exercise stimulates cognitive demand in working memory, executive function and attention and is correlated with dorsolateral prefrontal cortex activity.
Study NCT04897334 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Therapy
Description: During both the treatment and the sham intervention, participants will undero cognitive therapy training by performing the NBack task. In this sequential letter memory exercise participants are presented with sequential stimuli in the form of a series of letters. For each new stimulus they are asked to indicate if the current stimulus matches the stimulus from 2 trials prior. This exercise stimulates cognitive demand in working memory, executive function and attention and is correlated with dorsolateral prefrontal cortex activity.
Study NCT05750524 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: classical hand massage
Description: Classical hand massage methods applied randomly to both trial groups.
Study NCT06563323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Guselkumab
Description: Subjects with PG will be treated with 100 mg in a pre-filled syringe to be injected subcutaneously every 4 weeks for 28 weeks.
Study NCT05609097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PRIME
Description: PRIME is a a 'hybrid' aerobic-resistance (cardio and weights) program designed to target all major muscle groups and address the muscle limitations responsible for reduced fitness in the elderly. This occurs by minimizing the central limitations to more traditional exercise by delivering an ideal exercise stimulus to muscles in a way in which the heart is not a limiting factor. Each exercise involves contractions of specific isolated muscle groups with a moderate load, defined as 40%-50% of their maximal voluntary capacity.
Study NCT05609097 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: COMBO
Description: COMBO training includes both aerobic (cardio) and resistance (weightlifting) exercises. The aerobic component will be done on the stationary bicycle at 10-15 min duration at a target exercise intensity of 40-50% of VO2peak. This will feel like an intensity that is fairly light to somewhat hard, progressing gradually according to tolerance up to 20 mins. Intensity will be adjusted so that the difficulty remains in the target zone. The resistance component involves eight exercises, two sets of 10 repetitions, initially prescribed at 50-60% 1 repetition max. Subject will lift about half of their predicted maximal strength, 10 times, on 2 separate occasions with a rest between. Thereafter, the difficulty will be increased by approximately 10% when difficulty drops below the target range.
Study NCT05609097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COMBO
Description: COMBO training includes both aerobic (cardio) and resistance (weightlifting) exercises. The aerobic component will be done on the stationary bicycle at 10-15 min duration at a target exercise intensity of 40-50% of VO2peak. This will feel like an intensity that is fairly light to somewhat hard, progressing gradually according to tolerance up to 20 mins. Intensity will be adjusted so that the difficulty remains in the target zone. The resistance component involves eight exercises, two sets of 10 repetitions, initially prescribed at 50-60% 1 repetition max. Subject will lift about half of their predicted maximal strength, 10 times, on 2 separate occasions with a rest between. Thereafter, the difficulty will be increased by approximately 10% when difficulty drops below the target range.
Study NCT05163912 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual home intervention
Description: Group classes with active videogames and discussions
Study NCT05520216 — intervention group
Intervention type: DEVICE
Intervention: Spinal mouse (idiag m360)
Description: A noninvasive Spinal Mouse device will be used to measure the thoracic kyphosis and lumbar lordosis angle of the spinal column in the sagittal plane. It will be displayed on the computer aided software screen where the thoracic and lumbar region angles are calculated by swiping over the spinal processes from top to bottom with the Spinal Mouse (IDIAG m360) device. Measurements will be taken while standing on a flat surface. The volunteer will take off his upper clothes and shoes during the examination. Relax your arms and torso will be positioned next to you. The distance between the feet will be approximately waist width and parallel to each other, the knees will be straight and face motionless. He will stand where he feels comfortable. A Spinal Mouse examination will be performed and data will be recorded.
Study NCT05520216 — intervention group
Intervention type: BEHAVIORAL
Intervention: chest circumference measurement
Description: Measurements will be taken from the axillary (4th rib level - two fingers below the axilla), epigastric (xiphoid process level) and subcostal (9th rib level) regions at the time of normal, maximal inspiration, and maximal expiration using a tape measure while the patient is in a sitting position. The tape measure will be placed in the area to be measured. Care will be taken that there is no folding or horizontal level difference in the tape measure and that the fingers are not under the tape measure. Normal respiration will be measured first and recorded in centimeters (cm). The patient will then be asked to take a deep, long breath towards the bottom of the tape measure. The value obtained will be recorded as the deep inspiration value. Immediately after deep inspiration, the patient will be asked to make a deep and long expiration. The obtained value will be recorded as deep expiration.
Study NCT05520216 — intervention group
Intervention type: BEHAVIORAL
Intervention: Maximum Breath Hold Test
Description: During the breath-hold measurement, the subject will sit in a chair with a backrest. He will take a deep breath through his nose. We do not want maneuvers (Valsalva and Müller) and diaphragm contractions that will affect the breath-hold time, so volunteers will be observed throughout the test. The test will be terminated as soon as involuntary diaphragm contractions are seen. This test will be applied 3 times by resting the volunteer with breaks for 5 minutes. The average of 3 test results will be taken (Lin, Y. C.: Effect of O2 and CO2 on breath hold breaking point. In The Physiology of Breath Hold Diving. (eds): CEG Lundgren, M Ferringo, Undersea and Hyperbaric Medical Society Inc, Bethesda, Maryland, p: 75-87 1987.).
Study NCT05520216 — intervention group
Intervention type: BEHAVIORAL
Intervention: Sit and Reach
Description: While the participant is sitting on the floor with his back to the wall and his legs are fully extended in front of him, his knees should be in full contact with the floor. The box will be placed on the sole of the participant's feet (without shoes) in full contact with the volunteer's feet. The participant will be instructed to lean forward as slowly as possible, keeping their fingertips level with each other and their legs straight on the floor. He will be asked to slowly lie down along the ruler three times, and on the third attempt the volunteer will be instructed to reach out as far as possible and hold for 2 seconds. This value will be saved
Study NCT06572501 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the prone position
Description: This group of patients underwent robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the prone position
Study NCT06572501 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Robot-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the lateral position
Description: This group of patients underwent robotic-assisted laparoscopic partial nephrectomy via extraperitoneal approach in the lateral position
Study NCT06572696 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Shulder Ultrasound
Description: Ultrasound Shoulder Pathology Rating Scale (USPRS) will be used in the evaluation. While the participants are in a sitting position; A total of 5 variables, including bicipital tendinopathy, supraspinatus tendinopathy, greater tuberculum cortical surface irregularity, supraspinatus dynamic and subscapularis dynamic examination, are evaluated and scored according to the level of pathology; The total USPRS score is obtained by adding the scores of all variables.~Another parameter evaluated by ultrasonography in this study is the acromiohumeral distance measurement. In AH distance measurement with MSK-US, two measurements will be made with all participants in a neutral resting position and their hands at the top of the circle with the elbow angle of 110 °. In both positions, the probe will be placed longitudinally at the lateral point of the acromion determined by palpation, the distance determined between the acromion and the humeral head will be displayed and measured.
Study NCT04184882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bocidelpar
Description: Oral
Study NCT06573541 — intervention group
Intervention type: DEVICE
Intervention: Use of ultrasound
Description: Use of ultrasound in the initial management of patients in shock
Study NCT04184882 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bocidelpar
Description: Oral
Study NCT04184882 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral
Study NCT04434209 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Subject management guided by NephroCheck® test
Description: NephroCheck® is a device using biomarkers to identify subjects at risk of sepsis-associated acute kidney injury
Study NCT04434209 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care patient management
Study NCT05171920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Auxora
Description: All patients will receive 2.0 mg/kg (1.25 mL/kg) of Auxora at 0 hour and 1.6 mg/kg (1 mL/kg) at both 24 hours and 48 hours from the Start of the First Infusion of Auxora (SFIA) at 0 hour over 4 hours. Patients with severe hypoxemic respiratory failure at 48 hours will be randomized 1:1 to receive extended treatment with Auxora 1.6 mg/kg (1 mL/kg) at 72, 96, and 120 hours from the SFIA
Study NCT05171920 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients with severe hypoxemic respiratory failure at 48 hours will be randomized 1:1 to receive 1 mL/kg of Placebo at 72, 96, and 120 hours from the SFIA.
Study NCT06085105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CPIPE Training
Description: A two day training covering the following topics: understanding stress \& burnout and developing positive coping mechanisms, bias awareness \& mitigation, person-centered maternity care mindfulness, dealing with difficult situations, emergency obstetric and neonatal care, teamwork and communication, mentorship and peer support.
Study NCT06085105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer support groups
Description: Groups for healthcare providers to meet with other healthcare providers of their cadre, and discuss issues they are facing, brainstorm solutions, and provide support to one another.
Study NCT06085105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentorship
Description: Mentor-mentee relationships that provide the opportunity to coach junior healthcare providers on professional development, work-life balance, clinical skills, career advancement and other topics. Mentors develop their mentorship and leadership skills.
Study NCT05145647 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Add-on Brachytherapy
Description: Brachytherapy protocol starts within 2 weeks after consolidative EBRT, subjects who are enrolled will receive brachytherapy with specified balloon applicator. High-dose-rate (HDR) brachytherapy system will be used in the treatment, 5-Gy per fraction is delivered to the pre-treatment esophageal length of primary tumor(s), second treatment if applicable will be finished within 2 weeks after the first one, a total of 5-10Gy in 1-2 fractions will be delivered.
Study NCT05145647 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BRAXX Esophageal Brachytherapy Applicator
Description: The device is intended for use with commercially available afterloader during brachytherapy. The purpose of the device is for delivery of radioactive source to the esophagus. This device is sterile, disposable and single-use.
Study NCT06085105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Leadership engagement
Description: Engagement of County leadership at the onset of the project through a community advisory board, regular updates of the study and findings, and discussing systemic gaps that impact provider stress and bias.
Study NCT06085105 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Embedded champions
Description: To facilitate ongoing engagement and sustainability at the facility level, we identified facility champions who lead in organizing and facilitating peer support groups and refreshers at their facilities and serve as role models.
Study NCT05859126 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Maternal Choline Supplementation 930 mg/d
Description: Mothers were supplemented with choline (930mg/d) from second trimester through birth. This is a 13 year follow up of their offspring.
Study NCT05859126 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Maternal Choline Supplementation 480 mg/d
Description: Mothers were supplemented with choline (480 mg/d) from second trimester through birth. This is a 13 year follow up of their offspring.
Study NCT05234398 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood and saliva samplings
Description: At each protocol visits, on the occasion of a care collection, additional blood and saliva samples will be taken specifically for the study, with a total volume of blood of 38 mL, and a saliva sample of 1.5 to 2 mL per visit (inclusion, month 1, month 4, month 6, month 9 and month 12), corresponding to routine care.
Study NCT06568809 — intervention group
Intervention type: OTHER
Intervention: Time interval between recovery of body temperature and operation
Description: The time between body temperature recovery and surgery was collected as categorical factor and was scheduled to be analyzed in the following categories: 0-2 weeks; 3-4 weeks; 5-6 weeks; 7-8 weeks; And ≥ 3 months (control group).
Study NCT05155735 — intervention group
Intervention type: PROCEDURE
Intervention: Replantation
Description: Surgical reattachment of a severed body part
Study NCT05155735 — intervention group
Intervention type: PROCEDURE
Intervention: Primary wound closure
Description: Primary wound closure with removal of exposed bone
Study NCT04777461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey on patient's perspectives on the development of an structured education programme for PCOS
Description: The outcome of this survey will help with developing curriculum for the structured education programme.
Study NCT04777461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-pilot questionnaire
Description: The questionnaire is aimed to capture the knowledge and expectations of the participants from taking part in the educational sessions.
Study NCT04777461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Piloting the structured education programme for PCOS
Description: Piloting the education program through 2 educational group sessions
Study NCT04777461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post-pilot questionnaire
Description: The questionnaire aimed to capture participant's satisfactions and knowledge gained by taking part in the pilot study
Study NCT04777461 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognitive outcomes outcome evaluation form
Description: This aimed to capture skills developed, knowledge gained and changes in participants behaviour and perceptions by taking part in the pilot study.
Study NCT06542224 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deep Brain stimulation
Description: All subjects will receive bilateral surgical implantation of DBS system.
Study NCT04439097 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicomponent physical exercise program associated with a Mediterranean diet
Description: In this basic structure of each sessions, traditional exercises of mobility, strength, balance and coordination are included with the main objective of improving functional capacities. But, besides, games and some activities are also included with the aim, not only of improving the functional capacity, but also working the cognitive functions to reinforce the global effects.~The Mediterranean diet will based in these main foods: 1) vegetables; 2) fruits; 3) fish or seafood; 4) legumes; 5) nuts; 6) bread or cereals; 7) white meat; 8) eggs; and 9)olive oil.
Study NCT04439097 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care and participants continue with their life normally, without participating in a standardized exercise program, and they will be instructed to maintain their current physical activity level.
Study NCT05319418 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily Blood Pressure Monitoring
Description: Patients are provided standard off-the-shelf blood pressure monitors and take their BP vitals daily. Patients report their daily BP through phone or online. BP data is viewed online by physicians who use their independent medical judgement for any changes in medical management.
Study NCT06423937 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: combination therapy Combination: Fruquintinib plus Camrelizumab and HAIC (TOMOX/TOMIRI) Maintenance: Fruquintinib plus Camrelizumab
Description: Procedure/Surgery: HAIC After successful percutaneous hepatic artery cannulation, superior mesenteric arteriogram and hepatic arteriogram were performed, and after confirming that the subjects were eligible for enrollment according to the results, the hepatic artery was cannulated to the predetermined position. The catheter was connected to a syringe pump in the ward for continuous pumping of drugs.~TOMOX（Raltitrexed 2 mg/m2, Oxaliplatin 85mg/m2）/ TOMIRI（Raltitrexed 2 mg/m2 ，Irinotecan 120mg/m2） Drug: Fruquintinib 3mg, qd, po, 21 days for a cycle, Suspend medication on the day of HAIC Drug: Camrelizumab 200mg, ivgtt,, 21 days for a cycle
Study NCT05372198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chohort 1: Surufatinib
Description: Surufatinib 300mg, qd, every 3 weeks as a cycle
Study NCT05372198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chohort 2: Immunotherapy
Description: Refer to the instructions for the use of immunotherapy, every 3 weeks as a cycle
Study NCT05372198 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chohort 2: Surufatinib
Description: Surufatinib 250mg, qd, every 3 weeks as a cycle
Study NCT06460194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botuinum toxin
Description: Injection of botulinum toxin in the palm of the hand
Study NCT06020911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Biodentine
Description: 17 primary second molars of 17 children will be capped with Biodentine
Study NCT06020911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Theracal light cured
Description: 17 primary second molars of 17 children will be capped with Theracal light cured
Study NCT06460194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Botuinum toxin
Description: Injection of botulinum toxin in the palm of the hand
Study NCT05211219 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: According to the groups, they were involved simultaneously with the treatment, kefir group was advised to consume kefir as a liquid once a day in 14 days; the probiotics group was advised to consume as a chewable tablet once a day in 14 days; the control group was advised without additional food supplements.
Study NCT05211219 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: AOÇ Kefir
Description: AOÇ Kefir
Study NCT05211219 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Food without additional food supplements
Description: Food without additional food supplements
Study NCT05015803 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CBTi with Application
Description: Participants randomized to this study arm will experience an attempted enhancement of standard video conferencing CBTi, that is facilitated with electronic device-based data and resources to the clinician. Noninvasive ambulatory worn and nearable devices deliver feedback of data to the clinician on an application interface. This information will be used to inform the therapeutic approach and to facilitate a living-space environment that is conducive to effective therapy.
Study NCT05668494 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: immediate loading of implants
Description: This is a randomized control clinical trial including 24 implants, immediately loaded with definitive abutment protocol and 24 implants immediately loaded with with temporary abutment protocol
Study NCT05015803 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBTi
Description: Participants randomized to this study arm will experience standard CBTi that is delivered via video conferencing by a clinician, with some application interface use.